Stock Quote

AbbVie Inc. (NYSE:ABBV) ~ AbbVie’s hepatitis C treatment helps 96 pct of patients in trial

[Reuters] – AbbVie Inc said a late-stage trial of its experimental oral hepatitis C treatment showed about 96 percent of patients had no detectable levels of the virus after 12 weeks. The trial . . . → Read More: AbbVie Inc. (NYSE:ABBV) ~ AbbVie’s hepatitis C treatment helps 96 pct of patients in trial Similar posts: Market Update on McDonalds Corporation (NYSE:MCD) – McDonald’s helps workers get food stamps Stock Update: Johnson & Johnson (NYSE:JNJ) – J&J’s new hepatitis C drug gets positive FDA review Chevron goes to trial in New York over $18 billion Ecuador award – Chevron Corporation (NYSE:CVX)

AbbVie Inc. (NYSE:ABBV) [Reuters] – AbbVie Inc said a late-stage trial of its experimental oral hepatitis C treatment showed about 96 percent of patients had no detectable levels of the virus after 12 weeks. The trial is being watched closely …
Read more on this.

AbbVie Inc. (ABBV), with a current value of … [visit site to read more]

Similar posts:
  1. Market Update on McDonalds Corporation (NYSE:MCD) – McDonald’s helps workers get food stamps
  2. Stock Update: Johnson & Johnson (NYSE:JNJ) – J&J’s new hepatitis C drug gets positive FDA review
  3. Chevron goes to trial in New York over $18 billion Ecuador award – Chevron Corporation (NYSE:CVX)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.